INVERNIZZI, FEDERICA
INVERNIZZI, FEDERICA
Universita' degli Studi di MILANO
COVID-19 vaccine acceptance among liver transplant recipients
2021 A. Costantino, F. Invernizzi, E. Centorrino, M. Vecchi, P. Lampertico, M.F. Donato
Acute kidney injury and chronic kidney disease after liver transplant: A retrospective observational study
2021 F. Fabrizi, M.F. Donato, R. Cerutti, F. Invernizzi, G. Porata, G. Frontini, F. Raffiotta, T. De Feo, C.M. Alfieri, P. Lampertico, G. Rossi, P. Messa
Efficacy and safety of device-assisted enteroscopy ERCP in liver transplantation : a systematic review and meta-analysis
2020 F. Ferretti, M. Fraquelli, P. Cantu, R. Penagini, G. Casazza, M. Vecchi, S. Orlando, F. Invernizzi, F. Branchi, F.M. Donato, L. Elli
High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation : preliminary results
2020 G. Pisano, M.F. Donato, D. Consonni, G. Oberti, V. Borroni, R. Lombardi, F. Invernizzi, C. Bertelli, L. Caccamo, M. Porzio, D. Dondossola, G. Rossi, S. Fargion, A.L. Fracanzani
Health Status of Patients Who Underwent Liver Transplantation During the Coronavirus Outbreak at a Large Center in Milan, Italy
2020 M.F. Donato, F. Invernizzi, P. Lampertico, G. Rossi
Experience Wwith Early Sorafenib Treatment with Mtor Inhibitors in Hepatocellular Carcinoma Recurring after Liver Transplantation
2019 F. Invernizzi, M. Iavarone, C. Zavaglia, S. Mazza, U. Maggi, L. Cesarini, B.B. Antonelli, A. Airoldi, M.A. Manini, A. Sangiovanni, G. Rossi, M.F. Donato, L.S. Belli, P. Lampertico
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
2019 M. Iavarone, F. Invernizzi, C. Czauderna, M. Sanduzzi-Zamparelli, S. Bhoori, G. Amaddeo, M.A. Manini, M. Fraile López, M. Anders, M. Pinter, M.J. Blanco Rodríguez, M. Romero Cristóbal, G. Aballay Soteras, F. Piñero, G.E. Villadsen, A. Weinmann, G. Crespo, V. Mazzaferro, H. Regnault, M. De Giorgio, M.L. González-Diéguez, M.F. Donato, M. Varela, M. Wörns, J. Bruix, P. Lampertico, M. Reig
Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence
2017 M.F. Donato, F. Invernizzi, G. Rossi, M. Iavarone
Management of Biliary Anastomotic Strictures After Liver Transplantation (BASALT Study): a Nationwide Italian Survey
2017 P. Cantù, I. Parzanese, V. Balassone, A. Di Sario, F. Soggiu, G. Lombardi, F. Barbaro, A. Pisani, A. Baldan, G. Cariani, V. Boarino, A. Fasoli, H. Bertani, E. Forti, M. Bulajic, D. Ghinolfi, E. Nadal, A. Cerofolini, L. Barresi, G. Catalano, I. Stroppa, S. Traini, V. Mazzaferro, L. Cipolletta, A. Tringali, G. Costamagna, P. Ravelli, F. Bazzoli, A. Merighi, M. Caterina Parodi, R. Conigliaro, M. Mutignani, M. Zilli, F. Filipponi, A. Fantin, L. Rodella, I. Tarantino, M. Traina, M. Salizzoni, R. Rosa, F. Malinverno, F. Invernizzi, M. Manini, M.F. Donato, M. Colombo, D. Conte, G. Rossi, R. Penagini
Review article : The potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection
2016 M. Viganò, F. Invernizzi, G. Grossi, P. Lampertico
Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease
2016 M. Fraquelli, A. Baccarin, G. Casazza, C.B. Conti, M. Giunta, S. Massironi, F. Invernizzi, M.F. Donato, M. Maggioni, A. Aghemo, D. Conte, M. Colombo
The prognosis and management of inactive HBV carriers
2016 F. Invernizzi, M. Viganò, G. Grossi, P. Lampertico
Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts
2016 E. Onesto, C. Colombrita, V. Gumina, M.O. Borghi, S. Dusi, A. Doretti, G. Fagiolari, F. Invernizzi, M. Moggio, V. Tiranti, V. Silani, A. Ratti
Optimal therapy of chronic hepatitis B : how do I treat my HBeAg-negative patients?
2015 M. Viganò, F. Invernizzi, P. Lampertico
Treatment of recurrent hepatitis C with interferon-free regimens : better starting early
2015 F. Invernizzi, M. Colombo
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices : a 12-year prospective cohort study
2015 P. Lampertico, F. Invernizzi, M. Vigano', A. Loglio, G. Mangia, F. Facchetti, M. Primignani, M. Jovani, M.A. Iavarone, M. Fraquelli, G. Casazza, R. DE FRANCHIS, M.G. Colombo
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B
2015 C. Boni, P. Lampertico, L. Talamona, T. Giuberti, F. Invernizzi, V. Barili, P. Fisicaro, M. Rossi, M.C. Cavallo, A. Vecchi, G. Pedrazzi, A. Alfieri, M. Colombo, G. Missale, C. Ferrari
IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B
2013 P. Lampertico, M. Viganò, C. Cheroni, F. Facchetti, F. Invernizzi, V. Valveri, R.M. Soffredini, S. Abrignani, R. De Francesco, M.G. Colombo
Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B
2011 P. Lampertico, M. Viganò, F. Facchetti, F. invernizzi, A. Aroldi, G. Lunghi, P. Messa, M. Colombo